Ticker
IRDCompany Name
OPUS GENETICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 32.43M | 1.61 | $ 20.19M |
3/31/2025 | $ 41.79M | 1.72 | $ 24.25M |
12/31/2024 | $ 30.32M | 2.68 | $ 11.29M |
9/30/2024 | $ 36.63M | 6.02 | $ 6.09M |
6/30/2024 | $ 41.41M | 9.86 | $ 4.2M |
3/31/2024 | $ 47.16M | 8.15 | $ 5.79M |
12/31/2023 | $ 50.5M | 12.49 | $ 4.04M |
9/30/2023 | $ 42.35M | 10.83 | $ 3.91M |
6/30/2023 | $ 39.98M | 6.94 | $ 5.76M |
3/31/2023 | $ 38.99M | 9.39 | $ 4.15M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for OPUS GENETICS INC is calculated as follows: CashnEq [ $ 8.08M ] / LiabilitesC [ $ 3.01M ]
(=) Cash Ratio [ 2.69 ]
Minimum
Jun 30, 2025
Maximum
Dec 31, 2022
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |